Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B

Abstract

B-cell-specific plasma-membrane proteins are potential targets for either small molecule or antibody-based therapies. We have sought to annotate proteins expressed at the cell surface membrane in patients with chronic lymphocytic leukemia (CLL) using plasma-membrane-based proteomic analysis to identify previously uncharacterized and potentially B-cell-specific proteins. Proteins from plasma-membrane fractions were separated on one-dimensional gels and trypsinized fractions subjected to high-throughput MALDI-TOF mass spectrometry. Using this method, many known B-cell surface antigens were detected, but also known proteins not previously described in this disease or in this cellular compartment, including cell surface receptors, membrane-associated enzymes and secreted proteins, and completely unknown proteins. To validate the method, we show that BLK, a B-cell-specific kinase, is located in the CLL-plasma-membrane fraction. We also describe two novel proteins (MIG2B and B-cell novel protein #1, BCNP1), which are expressed preferentially in B cells. MIG2B is in a highly conserved and defined gene family containing two plasma-membrane-binding ezrin/radixin/moesin domains and a pleckstrin homology domain; the Caenorhabditis elegans homolog (UNC-112) is a membrane-associated protein that colocalizes with integrin at cell–matrix adhesion complexes. BCNP1 is a completely unknown protein with three predicted transmembrane domains, with three alternatively spliced final exons. Proteomic analysis may thus define new potential therapeutic targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 4

Similar content being viewed by others

References

  1. Rozman C, Montserrat E . Current concepts: chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052–1057.

    Article  CAS  Google Scholar 

  2. Kalil N, Cheson BD . Chronic lymphocytic leukemia. Oncologist 1999; 4: 352–369.

    CAS  PubMed  Google Scholar 

  3. Aalto Y, El-Rifai W, Vilpo L, Ollila J, Nagy B, Vihinen M et al. Distinct gene expression profiling in chronic lymphocytic leukemia with 11q23 deletion. Leukemia 2001; 15: 1721–1728.

    Article  CAS  Google Scholar 

  4. Stratowa C, Loffler G, Lichter P, Stilgenbauer S, Haberl P, Schweifer N et al. CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer 2001; 91: 474–480.

    Article  CAS  Google Scholar 

  5. Korz C, Pscherer A, Benner A, Mertens D, Schaffner C, Leupolt E et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002; 99: 4554–4561.

    Article  CAS  Google Scholar 

  6. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511.

    Article  CAS  Google Scholar 

  7. Voss T, Ahorn H, Harbel P, Wilgenbus K . Correlation of clinical data with proteomics profiles in 24 patients with B-cell chronic lymphocytic leukemia. Int J Cancer 2000; 91: 180–186.

    Article  Google Scholar 

  8. Pasquali C, Fialka I, Huber L-A . Subcellular fractionation, electromigration analysis and mapping of organelles. J Chromatogr B Biomed Sci Appl 1999; 722: 89–102.

    Article  CAS  Google Scholar 

  9. Eng J-K, McCormack A-L, Yates III J-R . An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein. J Am Soc Mass Spectrom 1994; 5: 976–989.

    Article  CAS  Google Scholar 

  10. Boyd RS, Duggan MJ, Shone CC, Foster KA . The effect of botulinum neurotoxins on the release of insulin from the insulinoma cell lines HIT-15 and RINm5F. J Biol Chem 1995; 270: 18216–18218.

    Article  CAS  Google Scholar 

  11. Pappin DJC, Hojrup P, Bleasby AJ . Rapid identification of proteins by peptide mass fingerprinting. Curr Biol 1993; 3: 327–332, also http://www.hgmp.mrc.ac.uk/Bioinformatics/Webapp/mowse.

    Article  CAS  Google Scholar 

  12. Adam PJ, Boyd R, Tyson KL, Fletcher GC, Stamps A, Hudson L et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer. J Biol Chem 2003; 278: 6482–6489.

    Article  CAS  Google Scholar 

  13. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI . Immunotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 2001; 61: 4483–4489.

    CAS  PubMed  Google Scholar 

  14. Hulkkonen J, Vilpo L, Hurme M, Vilpo J . Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia 2002; 16: 178–185.

    Article  CAS  Google Scholar 

  15. Treumann A, Lifely MR, Schneider P, Ferguson MA . Primary structure of CD52. J Biol Chem 1995; 270: 6088–6099.

    Article  CAS  Google Scholar 

  16. Burge C, Karlin S . Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997; 268: 78–94.

    Article  CAS  Google Scholar 

  17. Venkataraman C, Muthusamy N, Muthukkumar S, Bondada S . Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. J Immunol 1998; 160: 3322–3329.

    CAS  PubMed  Google Scholar 

  18. Majima S, Kajino K, Fukuda T, Otsuka F, Hino O . A novel gene ‘Niban’ upregulated in renal carcinogenesis cloning by the cDNA-amplified fragment length polymorphis approach. Jpn J Cancer Res 2000; 91: 869–874.

    Article  CAS  Google Scholar 

  19. Wick M, Burger C, Brusselbach S, Lucibello FC, Muller R . Identification of serum-inducible genes: different patterns of gene regulation during G0 → S and G1 → S progression. J Cell Sci 1994; 107: 227–239.

    CAS  PubMed  Google Scholar 

  20. Rogalski TM, Mullen GP, Gilbert MM, Williams BD, Moerman DG . The UNC-112 gene in Caenorhabditis elegans encodes a novel component of the cell–matrix adhesion structures required for integrin localization in the muscle membrane. J Cell Biol 2000; 150: 253–264.

    Article  CAS  Google Scholar 

  21. Mackinnon AC, Qadota H, Norman KR, Moerman DG, Williams BD . C. elegans PAT-4/ILK functions as an adaptor protein within integrin adhesion complexes. Curr Biol 2002; 14: 787–797.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grants from the Kay Kendall Leukemia Fund and the Leukemia Research Fund.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boyd, R., Adam, P., Patel, S. et al. Proteomic analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNP1 and MIG2B. Leukemia 17, 1605–1612 (2003). https://doi.org/10.1038/sj.leu.2402993

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402993

Keywords

This article is cited by

Search

Quick links